The purpose of this supplement is to provide an update on premature ejaculation (PE) and innovations in the treatment of this condition as presented during a satellite symposium that occurred on Monday, 5 December 2005, at the 8th Congress of the European Society for Sexual Medicine (ESSM), in Copenhagen, Denmark. Although PE is considered a common male sexual dysfunction, it is often an underdiagnosed and undertreated condition, and represents a new frontier in the study of male sexual health. Lifelong PE has been suggested to be a neurobiological dysfunction that might be responsible for an unacceptable increase of risk to develop sexual and psychological problems throughout the patient's lifetime. However, the stigma associated with PE often prevents sufferers from admitting to the condition and seeking professional help. Through continued education and presentation of updated information on men's sexual health, this supplement aims to increase awareness about a novel treatment for PE and its possible impact on the patient as well as patient-partner relationships.
1. Supplement objectives
- •Provide a historical overview of the evolution of PE treatment from 1900 to the present
- •Forge a discussion on the appropriate diagnosis and treatment of PE
- •Consider intra-European differences in patients’ attitudes toward PE
- •Evaluate the current impact of PE on patient-partner relationships
- •Discuss the rationale for a novel treatment approach to PE and provide updated clinical trial data
Published online: June 11, 2007
© 2007 Published by Elsevier Inc.